CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Overview Fund Activity
Delisted

CSCI was delisted on the 3rd of September, 2025.

Back to rankings

26 hedge funds and large institutions have $4.22M invested in COSCIENS Biopharma Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
9
Closed
6
Calls
$1.17M
Puts
$347K
Net Calls
+$819K
Net Calls Change
+$557K

Top Buyers

1
BlackRock
1
BlackRock
New York
$135K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$70K
3
BFM
3
Boothbay Fund Management
New York
$181K
4
SM
4
Sabby Management
Florida
$38K
5
Two Sigma Advisers
5
Two Sigma Advisers
New York
$35K

Top Sellers

1
JGC
1
J. Goldman & Co
New York
$59K
2
EI
2
EAM Investors
California
$0
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$0
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$0
5
HIM
5
Hillsdale Investment Management
Ontario, Canada
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
– -$315K -678 Closed
HIM
27
Hillsdale Investment Management
Ontario, Canada
– -$296K -631 Closed
VF
28
Virtu Financial
New York
– -$179K -385 Closed
Simplex Trading
29
Simplex Trading
Illinois
– -$22K -48 Closed
1
2